What does TI-RADS (Thyroid Imaging Reporting and Data System) 4 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TI-RADS 4: High Suspicion for Thyroid Malignancy

TI-RADS 4 indicates a thyroid nodule with high suspicion for malignancy, with approximately 32-84% positive predictive value for cancer, requiring fine needle aspiration (FNA) biopsy for definitive diagnosis. 1, 2

Understanding TI-RADS Classification

The American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) is a standardized classification system that stratifies thyroid nodules based on ultrasound characteristics to:

  • Guide management decisions
  • Predict probability of malignancy
  • Reduce unnecessary biopsies

The TI-RADS scoring system assigns points based on five ultrasound features:

  • Composition
  • Echogenicity
  • Shape
  • Margin
  • Echogenic foci (calcifications)

TI-RADS 4 Characteristics

TI-RADS 4 nodules typically demonstrate:

  • Moderately suspicious ultrasound features
  • Score of 7 points or more on the ACR TI-RADS scoring system
  • Higher risk of malignancy compared to TI-RADS 2 and 3 categories
  • Approximately 32-84% positive predictive value for malignancy 2

Management Recommendations for TI-RADS 4

The management of TI-RADS 4 nodules depends on size:

  • ≥1.0 cm: FNA biopsy recommended
  • 0.5-0.9 cm: FNA recommended if the nodule is ≥0.5 cm
  • <0.5 cm: Follow-up ultrasound recommended, biopsy generally not indicated

Diagnostic Accuracy and Limitations

  • TI-RADS 4 has higher specificity for malignancy than lower categories
  • Despite high suspicion, a significant percentage (64.6-78.9%) of TI-RADS 4 nodules may still be benign on cytology 1
  • Benign TI-RADS 4 nodules often have histopathological features like fibrosis that mimic malignancy on ultrasound 3

Common Pitfalls in TI-RADS 4 Assessment

  1. Overdiagnosis: Many TI-RADS 4 nodules are ultimately benign, leading to unnecessary biopsies
  2. Subcentimeter nodules: Routine biopsy of nodules <1 cm is generally not recommended despite suspicious features 4
  3. Histopathological mimics: Benign conditions like fibrosis can create suspicious ultrasound features 3
  4. Interpretation variability: Reader experience affects accurate categorization

Improving Diagnostic Accuracy

For TI-RADS 4 nodules with equivocal features, additional imaging modalities may be considered:

  • Shear wave elastography
  • Super microvascular imaging
  • Contrast-enhanced ultrasound
  • Artificial intelligence-assisted interpretation 5

These multimodal approaches may help reduce unnecessary biopsies while maintaining high sensitivity for detecting clinically significant malignancies.

Clinical Implications

TI-RADS 4 classification serves as an important risk stratification tool that balances the need to detect thyroid malignancies while minimizing unnecessary invasive procedures. The high positive predictive value for malignancy justifies the recommendation for FNA biopsy in appropriately sized nodules.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.